Thursday, August 07, 2014 8:33:17 PM
Also wanted to add that we are anticipating news on plans for a Phase 2 trial of MST 188 in Heart Failure. Non clinical results from earlier this year were very positive and May's Q-10 gives an early 2015 tentative date for the initiation of this promising trial.
We are also anticipating progress of the development of MST188 in resuscitation from shock/major trauma in collaboration with the Department of Defense.
Again, plenty of information available if you enjoy digging through their sec filings. Their next Q-10 is due very soon. I expected it on 8/4, but now it looks like Monday 8/11 is the next logical release date looking at past practice.
RR
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM